GleamWall
中文EN

RCKT ROCKET PHARMACEUTICALS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1281895 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY93.3%
TTM EPS YoY93.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-5.0%
ROA-4.1%
ROIC (approx.)-60.4%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets22.1%
Debt / equity0.09x
Current ratio7.26x
Interest coverage-100.61x

Cash quality & payout

Operating cash flow / net income9.84x
Accruals ratio36.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0$0
R&D expense$142.01M$171.24M
SG&A expense$86.50M$101.96M
Operating income-$231.75M-$273.20M
Interest expense$1.89M$1.89M
Pretax income-$223.12M-$258.75M
Income tax$0$0
Net income-$223.12M-$258.75M
EBITDA-$222.85M-$266.00M
EPS (basic)-2.01-2.73
EPS (diluted)-2.01-2.73
Weighted avg. shares (diluted)111.12M94.81M
Balance sheet
Cash & equivalents$77.56M$165.00M
Short-term investments$111.37M$208.70M
Inventory$0—
Current assets$192.73M$378.18M
PP&E, net$28.17M$36.79M
Goodwill$39.15M$39.15M
Intangibles$25.15M$25.15M
Total assets$330.45M$527.70M
Current liabilities$30.21M$40.68M
Long-term debt$0—
Total debt$0—
Total liabilities$53.23M$64.47M
Shareholders' equity$277.22M$463.23M
Net debt-$77.56M—
Shares outstanding108.32M106.45M
Cash flow statement
Operating cash flow-$190.01M-$209.72M
Capital expenditure$440,000$5.86M
Free cash flow-$190.45M-$215.59M
Investing cash flow$103.77M$131.71M
Financing cash flow$148,000$185.74M
Depreciation & amortization$8.90M$7.20M
Stock-based compensation$37.06M$43.92M

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.